Aquablation therapy robotic treatment first in bistate area
June 02, 2023
BPH, or an enlarged prostate, is a non-cancerous condition where the prostate has grown to be larger than normal. 1 in 2 men ages 51 to 60 have BPH, and the incidence increases every decade of life if left untreated. Risk factors include a man’s age; heredity (father who had BPH); weight; inactivity; and sometimes erectile dysfunction.
BPH can cause significant health problems, including irreversible bladder or kidney damage, bladder stones, and incontinence. An issue with current BPH surgical treatments is that they often force men to trade-off between symptom relief and side effects, limiting patients to choosing between either a high degree of symptom relief with high rates of irreversible complications (such as incontinence, erectile dysfunction, or ejaculatory dysfunction) or a low degree of symptom relief with low rates of irreversible complications.
Aquablation therapy is a different type of treatment for BPH. It’s an advanced, minimally invasive treatment that uses the power of water delivered with robotic precision to provide best-in-class and long-lasting symptom relief with low rates of irreversible complications, regardless of prostate size or shape.
Aquablation therapy is performed by the AquaBeam Robotic System, the first FDA-cleared surgical robot utilizing automated tissue resection for the treatment of LUTS due to BPH. It combines real-time, multi-dimensional imaging, automated robotic technology, and heat-free waterjet ablation technology for targeted, controlled, and immediate removal of prostate tissue.
Since every prostate is unique in shape and size, the imaging map created is customized and tailored to every patient’s unique anatomy.
Men living with BPH should speak to their primary care physician or urologist to see if this new technology could improve their health and quality of life.
